These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 28737131

  • 21. Peri-operative renal morbidity secondary to gentamicin and flucloxacillin chemoprophylaxis for hip and knee arthroplasty.
    Ross AD, Boscainos PJ, Malhas A, Wigderowitz C.
    Scott Med J; 2013 Nov; 58(4):209-12. PubMed ID: 24215038
    [Abstract] [Full Text] [Related]

  • 22. Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study.
    Wing K, Bhaskaran K, Pealing L, Root A, Smeeth L, van Staa TP, Klungel OH, Reynolds RF, Douglas I.
    J Antimicrob Chemother; 2017 Sep 01; 72(9):2636-2646. PubMed ID: 28859440
    [Abstract] [Full Text] [Related]

  • 23. Relationship between plasma and bone concentrations of cefuroxime and flucloxacillin. Three different parenteral administrations compared in 30 arthroplasties.
    Alvarez Ferrero MM, Vree TB, Van Ewijk-Beneken Kolmer EW, Slooff TJ.
    Biopharm Drug Dispos; 1994 Oct 01; 15(7):599-608. PubMed ID: 7849235
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Examination of stability and compatibility of flucloxacillin (Floxapen) and ceftazidime (Fortum) in two infusion media: relevance for the clinical praxis].
    Thalhammer F, Maier-Salamon A, Jäger W.
    Wien Med Wochenschr; 2005 Jul 01; 155(13-14):337-43. PubMed ID: 16092041
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Protein binding of flucloxacillin in neonates.
    Pullen J, Stolk LM, Degraeuwe PL, van Tiel FH, Neef C, Zimmermann LJ.
    Ther Drug Monit; 2007 Jun 01; 29(3):279-83. PubMed ID: 17529883
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R, Polkinghorne KR, Kerr PG.
    Am J Kidney Dis; 2008 Jul 01; 52(1):93-101. PubMed ID: 18423807
    [Abstract] [Full Text] [Related]

  • 31. Plasma, bone, hip capsule and drain fluid concentrations of ampicillin and flucloxacillin during total hip replacement after intravenous bolus injection of magnapen.
    Parsons RL, Beavis JP, Laurence M, David JA, Paddock GM, Trounce JR.
    Br J Clin Pharmacol; 1978 Aug 01; 6(2):135-43. PubMed ID: 678390
    [Abstract] [Full Text] [Related]

  • 32. Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
    de Wildt SN, de Hoog M, Vinks AA, van der Giesen E, van den Anker JN.
    Crit Care Med; 2003 Jul 01; 31(7):1952-8. PubMed ID: 12847388
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prolonged hepatic cholestasis after flucloxacillin therapy.
    Turner IB, Eckstein RP, Riley JW, Lunzer MR.
    Med J Aust; 2003 Jul 01; 151(11-12):701-5. PubMed ID: 2593915
    [Abstract] [Full Text] [Related]

  • 36. Bone penetration of intravenous flucloxacillin and gentamicin as antibiotic prophylaxis during total hip and knee arthroplasty.
    Torkington MS, Davison MJ, Wheelwright EF, Jenkins PJ, Anthony I, Lovering AM, Blyth M, Jones B.
    Bone Joint J; 2017 Mar 01; 99-B(3):358-364. PubMed ID: 28249976
    [Abstract] [Full Text] [Related]

  • 37. Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency.
    Haubitz M, Bohnenstengel F, Brunkhorst R, Schwab M, Hofmann U, Busse D.
    Kidney Int; 2002 Apr 01; 61(4):1495-501. PubMed ID: 11918757
    [Abstract] [Full Text] [Related]

  • 38. Retrospective analysis of a flucloxacillin oral absorption test in patients requiring flucloxacillin therapy: results and determination of factors associated with adequate absorption.
    De Smet S, De Cock P, Verougstraete N, Buyle F, Boelens J, Huis In 't Veld D.
    Acta Clin Belg; 2024 Jun 01; 79(3):184-192. PubMed ID: 39054877
    [Abstract] [Full Text] [Related]

  • 39. [Pharmacokinetics of triamterene and its active metabolites in renal insufficiency (author's transl)].
    Grebian B, Geissler HE, Knauf H, Mutschler E, Schnippenkoetter I, Völger KD, Wais U.
    Arzneimittelforschung; 1978 Jun 01; 28(8):1420-5. PubMed ID: 582410
    [Abstract] [Full Text] [Related]

  • 40. A role for the pregnane X receptor in flucloxacillin-induced liver injury.
    Andrews E, Armstrong M, Tugwood J, Swan D, Glaves P, Pirmohamed M, Aithal GP, Wright MC, Day CP, Daly AK.
    Hepatology; 2010 May 01; 51(5):1656-64. PubMed ID: 20222094
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.